Many people experience mild gastrointestinal symptoms during dose escalation, which often improve as the body adjusts to treatment
Similarly, older adults, those with digestive disorders like Crohns disease or celiac disease, and individuals whove undergone weight-loss surgery may struggle with the bodys ability to absorb B12 from food
Emergency Medicine Clinics of North America
Most people lose 38 pounds in the first month once their starter dose is established, with appetite suppression often noticeable within days
The inclusion in compounded tirzepatide provides a small but consistent weekly dose
However, when obesity is leading to severe metabolic complications, then using GLP-1 agonists as a PART of your management strategy may, in fact, be life-changing and even life-saving